New post (Rexahn Pharmaceuticals, Inc (NYSEMKT:RNN) Initiates - TopicsExpress



          

New post (Rexahn Pharmaceuticals, Inc (NYSEMKT:RNN) Initiates Phase-Iia Clinical Proof-Of-Concept Trial) (Boston, MA, 01/27/2014 (nysepost) - In Mid-January, Rexahn Pharmaceuticals, Inc (NYSEMKT:RNN) announced that it had initiated its Phase-IIa clinical proof-of-concept trial via which it will study the efficacy and the safety of Archexin® in the patients suffering from metastatic renal cell car...) has been published on NYSE Post
Posted on: Mon, 27 Jan 2014 13:29:50 +0000

Trending Topics



Recently Viewed Topics




© 2015